Clinical trial
Macular Edema Incidence/Severity Reduction With Nevanac
NCT00939276 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Macular Edema Incidence/Severity Reduction With Nevanac
- Lead sponsor
- Alcon Research
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- August 31, 2009
- Completion date
- August 31, 2011
- Enrollment
- 175 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.